Lymphopenia combined with low TCR diversity to predict overall survival in metastatic breast cancer patients.

10562 Background: Lymphopenia (<1 Giga/L) before initiation of chemotherapy is a predictive factor for toxicity and death in metastatic phase for cancer patients. Combinatorial diversity of T Cell ...